$SNPS

Synopsys Prediction: Analysts See 25% Upside After Q3 Beat and Raised Guidance

Synopsys reported Q3 FY2026 revenue of $2.48B, up 42.4% YoY, and raised full-year guidance. Analysts at 24/7 Wall St. predict a 25% upside to $496.97, citing strong fundamentals and AI-driven growth. However, shares are down 15.45% YTD due to China-related challenges and high valuation.

Original reporting
Published Sep 12, 2026, 3:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 13, 2026, 4:50 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$SNPS
Bullish
high confidence
Mentioned
$SNPS
Relevance
8/10
AlphAI data visualization · based on kobaran.com
Decision brief

The 30-second read

$SNPSBullishMed
01

Why it matters

The earnings beat and guidance lift suggest a re‑rating opportunity, but execution risk from China restrictions and integration costs remain.

02

Market read

Strong earnings and guidance could narrow the gap between price and analyst targets, influencing AI‑related tech stocks.

03

What to watch

High restructuring and amortization charges may pressure GAAP earnings despite non‑cash nature.

Relevance 8/10Novelty 8/10Timing: post‑earnings release today

Background

Synopsys' Q3 results and guidance raise come amid AI‑driven demand and ongoing Ansys integration.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys reported Q3 FY2026 revenue of $2.48B and raised full-year guidance to $9.715B revenue and $15.07 EPS.

Expected impact

Potential upside of 15‑25% if market digests the guidance lift.

Evidence & confidence

Guidance raise and strong revenue growth address prior price lag, aligning with analyst buy models.

Market effects

Highlights AI‑driven demand in EDA and simulation, supporting sector peers.

U.S. tech sector may see modest lift; China exposure remains a risk.

Reinforces broader AI‑related growth narrative across markets.

Counterpoint

China export controls could dampen near‑term demand, limiting upside.

Key entities

  • Synopsys

    EDA software provider reporting Q3 results.

  • Ansys

    Acquired firm whose integration drives future synergies.

Related articles

$SNPSMed

Is Synopsys Back from the Dead? EDA Leader Inks Deals With Amazon and OpenAI

Synopsys (SNPS) shares have rebounded over 30% since September, driven by a $1B+ deal with Amazon (AMZN) and a partnership with OpenAI. The Amazon deal focuses on Synopsys' IP business, with royalties expected to grow. The OpenAI collaboration aims to accelerate chip development. Synopsys raised its FY2030 revenue growth outlook to mid-teens CAGR and adjusted operating margin to 50%.

$SNPSHigh

Can Synopsys Stock Drop From Here?

Synopsys (SNPS) stock rose 28% in a month, outpacing the S&P 500, after updating growth targets and partnering with OpenAI. Q3 2026 revenue grew 8.5% for chip design tools, with total revenue at $2.477B, including $711M from Ansys. Management expects double-digit growth in Q4, driven by AI demand. Operating margin is 11.0%, below the S&P 500's 18.5%, with $10B in debt. Cash flow forecast raised to $2.8B, and $1B stock buyback announced.